awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42720284-4FC47B43-948A-4A1F-981A-71641135E29A
Q42720284-4FC47B43-948A-4A1F-981A-71641135E29A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-4FC47B43-948A-4A1F-981A-71641135E29A
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.
P2860
Q42720284-4FC47B43-948A-4A1F-981A-71641135E29A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-4FC47B43-948A-4A1F-981A-71641135E29A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4188eaf6dd1d8278def7171e8d27995f8892c6e4
P2860
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.